# IBSA Group expands Lodi production site with €13.5M investment

IBSA Group inaugurated its renovated production facility in Lodi, Italy, following a €13.5 million expansion project that increases production capacity of hyaluronic acid-based products from 6 million to 14 million units per year.

- Type: Expansion
- Announced: 2026-10-05
- Where: Lodi, Italy, Italy
- Value: $14.8M (13.5M EUR)
- Starts operating: 5 Oct 2026
- Status: completed
- Capacity: 14 million units per year
- Products: hyaluronic acid-based products, pre-filled syringe formulations
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [IBSA Group](https://endata.com/companies/94480.md)

## Sources

- [ibsagroup.com](https://www.ibsagroup.com/media/news/2026/expanding-the-lodi-production-site-italy.html), 2026-10-07: "The overall investment of €13.5 million strengthens the site's role within IBSA's production network and supports its growth in international markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.